Levodopa

Chemical Name: Levodopa
CAS No.:  59-92-7

Chemical Structure:C9H11NO4

Molecular weight:  197.19

Properties: This product is a white crystalline powder.

Purity: >98%

Treatment of Parkinson's Disease:
Levodopa is a core therapeutic drug for Parkinson's disease. The core issue in Parkinson's disease is the degeneration and death of dopaminergic neurons in the substantia nigra of the midbrain, leading to a decrease in dopamine levels. Levodopa can cross the blood-brain barrier and be converted into dopamine in the brain, thereby supplementing the deficiency of dopamine in the brain and effectively alleviating the symptoms of Parkinson's disease, such as tremor, muscle rigidity, and bradykinesia.

Antihyperalgesia Effect:

Levodopa has the potential for antihyperalgesia, which may help reduce certain pain states.

Animal Modeling:

In scientific research, Levodopa can be used to create animal models, such as rat models of dyskinesia, to further understand the pathogenesis of Parkinson's disease and other related diseases.